A new consumer data set projects that Canadian cannabis consumers will spend over C$1,600 a year on cannabis products by 2025.

On Tuesday (March 26), research and business firm EY announced that the average Canadian cannabis consumer’s spending on cannabis products will increase 30 percent by 2025.

The study is projecting an increase from C$1,263 annually from consumers in 2019 to C$1,652 by 2025.

US Election 2020 and Cannabis

Investing in cannabis? Read what experts have to say about cannabis and the US Election!

The data indicates that the overall Canadian cannabis market will grow by 50 percent to reach C$11 billion in 2025.

EY projects that the supply of cannabis will top demand within the next five years.

According to the firm, if this prediction comes true, the average cost of wholesale dried flower will decrease to between C$4 and C$5.

In February, The GrowthOp reported on the average price of dried marijuana for each province in Canada.

In arguing against the notion that increasing costs for legal marijuana products pushes consumers towards the illicit market, Zachary Pendley, EY Canada cannabis real estate and valuation leader, said the consumer trend is due to the slower-than-expected rollout for retail.

“As the industry matures, access to product eases and higher margin derivatives come online, we’ll see a rise in consumer spending on legal cannabis,” Pendley said in a press release.

On the road to the legalization of recreational marijuana in October 2018, provinces were tasked with setting up retail models.

However, the process wasn’t smooth for every area, with Ontario and BC conducting slower rollouts for the markets. Ontario is still set to open its privatized retail market starting April 1, with some shops opening their doors later.

The study also projects that, by the year 2025, 20 percent of the total adult population will be cannabis consumers.

In addition, it indicates how consumption trends for different types of products are set to change.

Consumption splits from EY show dried flower will command a leading 46-percent market share, with extracts securing 37-percent of the market by 2025.

Edibles will only obtain a 12-percent share, and non-edible derivatives placed last with a 5-percent market share. Both are scheduled to become legal in Canada on or before October 17, 2019.

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

Strong Innovation Pipeline Continues to Drive Market Share Growth
Broken Coast’s First Foray into Cannabis 2.0
Solei Introduces First Limited Release Vape on the Market
Solei, RIFF, Good Supply and B!NGO Expand Product Offerings

Aphria Inc. (” Aphria ” or the ” Company “) ( TSX: APHA and NASDAQ: APHA ), a leading global cannabis company inspiring and empowering the worldwide community to live their very best life, today announced the expansion of its 510 Vape offering across its award-winning adult-use brand portfolio.

Keep reading... Show less

Zhang Investor Law announces a class action lawsuit on behalf of shareholders who bought shares of Aurora Cannabis Inc. (NYSE: ACB) between February 13, 2020 and September 4, 2020, inclusive (the “Class Period”). If you wish to serve as lead plaintiff, you must move the Court before the December 1 2020 DEADLINE . A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

To join the class action, go to http://zhanginvestorlaw.com/join-action-form/?slug=aurora-cannabis-inc&id=2437 or call Sophie Zhang, Esq. toll-free at 800-991-3756 or email info@zhanginvestorlaw.com for information on the class action.

Keep reading... Show less

Nextleaf Solutions Ltd. (CSE: OILS) (OTCQB: OILFF) (“Nextleaf Solutions“, “OILS”, or the “Company”), Canada’s most innovative cannabis extractor, is pleased to provide the following commercial and intellectual property update:

Cannabis Extraction Agreement with White Label Producer

Keep reading... Show less


Khiron Life Sciences Corp. (“ Khiron ” or, the “ Company ”) (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America and Europe, is pleased to announce that it has closed today its previously announced “bought deal” short form prospectus offering of units (“ Unit s ”), including the exercise in full of the over-allotment option (the “ Offering ”).

Keep reading... Show less

Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”), an innovative global cannabinoid company, today announced that Mike Gorenstein, Executive Chairman, is scheduled to speak on a panel at the Cowen 2020 Boston Cannabis Conference on Wednesday, December 2, 2020 at 9:20 a.m. EST.

For more information regarding the Cowen 2020 Boston Cannabis Conference please visit: https://www.cowen.com/conferences-and-events/3rd-annual-boston-cannabis-conference/

Keep reading... Show less